VEDAMURTHY, M.; HUMBERT, P. A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma. International Journal of Research in Dermatology, [S. l.], v. 4, n. 4, p. 471–478, 2018. DOI: 10.18203/issn.2455-4529.IntJResDermatol20184453. Disponível em: https://www.ijord.com/index.php/ijord/article/view/211. Acesso em: 10 feb. 2025.